Is Neoadjuvant Therapy Sufficient in Resected Pancreatic Cancer Patients? A National Study

Author(s):
Geus, S.W.L. de; Kasumova, G.G.; Eskander, M.F.; Ng, S.C.; Kent, T.S.; Moser, A.J.; Vahrmeijer, A.L.; Callery, M.P.; Tseng, J.F.
Published
2018
Publication type
Article / Letter to editor
Pancreatic neoplasmsNeoadjuvant therapyAdjuvant chemotherapySurvival
Date issued
2018-02-28
Language
English
Is part of
Journal of Gastrointestinal Surgery (2018), Vol. 22, no. 2, p. 214-225
hdl
1887/95250
doi
10.1007/s11605-017-3541-8